patents

Stryker’s Howmedica owes $13m in fees in Zimmer Biomet patent spat
Stryker’s Howmedica owes $13m in fees in Zimmer Biomet patent spat
Mass Device
Stryker
Homedica
Zimmer Biomet
patents
devices
Flag link:
Indivior Reaches Patent Infringement Settlement With Par Pharmaceutical Over Suboxone
Indivior Reaches Patent Infringement Settlement With Par Pharmaceutical Over Suboxone
CP Wire
Individor
Par Pharmaceutical
Suboxone Film
Suboxone
patents
Flag link:
Judge sanctions Boston Scientific lawyers in Nevro patent row
Judge sanctions Boston Scientific lawyers in Nevro patent row
Mass Device
Boston Scientific
Nevro
devices
patents
neurostimulation
Flag link:
Lilly, Pfizer, Sanofi lead in patent litigation, report says
Lilly, Pfizer, Sanofi lead in patent litigation, report says
Biopharma Dive
Eli Lilly
Sanofi
Pfizer
patents
patent lawsuits
FDA
Flag link:
Kura Recieves New Patent for Tipifarnib in Lymphoma and Acute Myeloid Leukemia
Kura Recieves New Patent for Tipifarnib in Lymphoma and Acute Myeloid Leukemia
CP Wire
Kura Oncology
tipifarnib
patents
AML
PTCL
Flag link:
New Patent Related Suit Against Shire Could Have Value Into the Billions
New Patent Related Suit Against Shire Could Have Value Into the Billions
CP Wire
Shire
Vyvanse
fraud
patents
Flag link:
U.S. court upholds dismissal of $200 million Merck verdict against Gilead
U.S. court upholds dismissal of $200 million Merck verdict against Gilead
Reuters
Merck
Gilead Sciences
patents
hepatitis C
Flag link:
Interview With Hatch-Waxman Expert Kurt Karst
Interview With Hatch-Waxman Expert Kurt Karst
CP Wire
FDA
Hatch Waxman Act
patents
Flag link:
Should Sarepta’s patents be seized by the government? Patient advocates pitch controversial drug pricing proposal
Should Sarepta’s patents be seized by the government? Patient advocates pitch controversial drug pricing proposal
Endpoints
Sarepta Therapeutics
patients
patents
Exondys 51
Duchenne Muscular Dystrophy
Flag link:
Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers
Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers
CP Wire
Individor
Suboxone Film
patents
Dr Reddy's
Actavis
Par Pharmaceutical
Teva Pharmaceutical
Alvogen
Flag link:
Drug Wars: Companies Fight Patents In Court With A Fortune At Stake
Drug Wars: Companies Fight Patents In Court With A Fortune At Stake
American Council on Science and Health
patents
generics
innovation
Flag link:
Allergan's much-maligned tribal licensing deal wins reprieve at appeals court
Allergan's much-maligned tribal licensing deal wins reprieve at appeals court
Fierce Pharma
Allergan
Restasis
patents
Flag link:
Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict
Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict
Reuters
Teva Pharmaceutical
GSK
patents
Coreg
Flag link:
In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen
In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen
Endpoints
Indivior
patents
Suboxone
Alvogen
generics
Flag link:
Tribe looks to stop patent board’s review of Restasis IP
Tribe looks to stop patent board’s review of Restasis IP
Drug Delivery Business News
Allergan
Restasis
intellectual property
patents
Flag link:
Appeals court upholds patent ruling for Smith & Nephew
Appeals court upholds patent ruling for Smith & Nephew
Mass Device
Smith & Nephew
devices
patents
Covidien
Hologic
endoscopes
Flag link:
Alphabet Has Filed 186 Health Care Patents. Watch Out, World
Alphabet Has Filed 186 Health Care Patents. Watch Out, World
Forbes
Alphabet
patents
Apple
Microsoft
data
wearables
Flag link:
Senators heap abuse on Allergan’s attempt at an end run around patent reviews, offer bill to stop ‘sham’
Senators heap abuse on Allergan’s attempt at an end run around patent reviews, offer bill to stop ‘sham’
Endpoints
Senate
Allergan
patents
Restasis
inter partes review
Flag link:
Sovereign nonsense: Patent board joins the lineup of critics dissing Allergan’s ‘illusory’ IP deal with the Mohawks
Sovereign nonsense: Patent board joins the lineup of critics dissing Allergan’s ‘illusory’ IP deal with the Mohawks
Endpoints
Allergan
patents
Restasis
Flag link:
Allergan is dealt another setback as patent board shoots down Mohawk patent deal
Allergan is dealt another setback as patent board shoots down Mohawk patent deal
Stat
Allergan
patents
Flag link:

Pages